Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Conditions
- Cervical Squamous Cell Carcinoma
- Recurrent Cervical Cancer
Interventions
- BIOLOGICAL: bevacizumab
- OTHER: laboratory biomarker analysis
Sponsor
National Cancer Institute (NCI)
Collaborators